CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21

Description

Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI M43-A

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE

$90.00 $180.00

CLSI EP23-A (R2018)

Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE

$90.00 $180.00

CLSI VET05-R (R2018)

Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE

$90.00 $180.00

CLSI QMS13-A (R2018)

Quality Management System: Equipment; Approved Guideline, QMS13AE

$90.00 $180.00